{"transactions":[{"id":4685,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10168,"kind":"person","name":"Chell Jeffrey W.","position":1,"cik":"0001738374","reported_name":"Chell Jeffrey W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-04T21:00:23.000Z","date":"2026-09-02","kind":"grant","planned":false,"acquired":true,"shares":92400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in fifty equal monthly tranches beginning on the date of grant."}],"balance_after":92400,"derivative":{"exercise_price":1,"expiration_date":"2036-09-02","underlying":"Common Stock","underlying_shares":92400},"source":{"system":"sec-edgar","filing":"0001213900-26-097739","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1738374/000121390026097739/ownership.xml","form_type":"4"}},{"id":4684,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10168,"kind":"person","name":"Chell Jeffrey W.","position":1,"cik":"0001738374","reported_name":"Chell Jeffrey W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-04T21:00:23.000Z","date":"2026-09-02","kind":"grant","planned":false,"acquired":true,"shares":61600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\"). The RSUs vest as follows: 1/3 on the first anniversary of the date of grant, 1/3 on the second anniversary of the date of grant and 1/3 on the third anniversary of the date of grant."}],"balance_after":61600,"source":{"system":"sec-edgar","filing":"0001213900-26-097739","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1738374/000121390026097739/ownership.xml","form_type":"4"}},{"id":1182810,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10168,"kind":"person","name":"Chell Jeffrey W.","position":1,"cik":"0001738374","reported_name":"Chell Jeffrey W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T22:22:19.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":70311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."}],"balance_after":0,"derivative":{"exercise_price":5,"expiration_date":"2033-12-28","underlying":"Common Stock","underlying_shares":70311},"source":{"system":"sec-edgar","filing":"0001213900-25-028231","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390025028231/ownership.xml","form_type":"4"}},{"id":1182809,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10168,"kind":"person","name":"Chell Jeffrey W.","position":1,"cik":"0001738374","reported_name":"Chell Jeffrey W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T22:22:19.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":72156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."}],"balance_after":0,"derivative":{"exercise_price":4.96,"expiration_date":"2032-07-01","underlying":"Common Stock","underlying_shares":72156},"source":{"system":"sec-edgar","filing":"0001213900-25-028231","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390025028231/ownership.xml","form_type":"4"}},{"id":1182808,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10168,"kind":"person","name":"Chell Jeffrey W.","position":1,"cik":"0001738374","reported_name":"Chell Jeffrey W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T22:22:19.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":18351,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."}],"balance_after":0,"derivative":{"exercise_price":6.07,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":18351},"source":{"system":"sec-edgar","filing":"0001213900-25-028231","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390025028231/ownership.xml","form_type":"4"}},{"id":1182807,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10168,"kind":"person","name":"Chell Jeffrey W.","position":1,"cik":"0001738374","reported_name":"Chell Jeffrey W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T22:22:19.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."}],"balance_after":0,"derivative":{"exercise_price":9.55,"expiration_date":"2030-08-12","underlying":"Common Stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001213900-25-028231","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390025028231/ownership.xml","form_type":"4"}},{"id":1182806,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10168,"kind":"person","name":"Chell Jeffrey W.","position":1,"cik":"0001738374","reported_name":"Chell Jeffrey W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T22:22:19.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."}],"balance_after":0,"derivative":{"exercise_price":6.96,"expiration_date":"2029-07-12","underlying":"Common Stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001213900-25-028231","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390025028231/ownership.xml","form_type":"4"}},{"id":1182805,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10168,"kind":"person","name":"Chell Jeffrey W.","position":1,"cik":"0001738374","reported_name":"Chell Jeffrey W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T22:22:19.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."}],"balance_after":0,"derivative":{"exercise_price":23.49,"expiration_date":"2028-07-13","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001213900-25-028231","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390025028231/ownership.xml","form_type":"4"}},{"id":1182804,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10168,"kind":"person","name":"Chell Jeffrey W.","position":1,"cik":"0001738374","reported_name":"Chell Jeffrey W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T22:22:19.000Z","date":"2025-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration."}],"balance_after":0,"derivative":{"exercise_price":10.41,"expiration_date":"2028-04-27","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001213900-25-028231","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390025028231/ownership.xml","form_type":"4"}},{"id":1697774,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10168,"kind":"person","name":"Chell Jeffrey W.","position":1,"cik":"0001738374","reported_name":"Chell Jeffrey W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-29T22:15:37.000Z","date":"2023-12-28","kind":"grant","planned":false,"acquired":true,"shares":70311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This price represents the closing price of the Issuer's common stock on December 28, 2023, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Issuer's 2019 Stock Plan, 2% of the options will vest each month from the date of grant until fully vested."}],"balance_after":70311,"derivative":{"exercise_price":5,"expiration_date":"2033-12-28","underlying":"Common Stock","underlying_shares":70311},"source":{"system":"sec-edgar","filing":"0001213900-23-100057","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390023100057/ownership.xml","form_type":"4"}},{"id":2216797,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10168,"kind":"person","name":"Chell Jeffrey W.","position":1,"cik":"0001738374","reported_name":"Chell Jeffrey W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-01T23:11:44.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":72156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This price represents the closing price of the Company's common stock on July 1, 2022, the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Company's 2019 Stock Plan, 2% of the options will vest each month from July 1, 2022 until fully vested."}],"balance_after":72156,"derivative":{"exercise_price":4.96,"expiration_date":"2032-07-01","underlying":"Common Stock","underlying_shares":72156},"source":{"system":"sec-edgar","filing":"0001213900-22-036866","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390022036866/ownership.xml","form_type":"4"}},{"id":2578645,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10168,"kind":"person","name":"Chell Jeffrey W.","position":1,"cik":"0001738374","reported_name":"Chell Jeffrey W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-03T21:05:06.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":18351,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from September 1, 2021 until fully vested."}],"balance_after":18351,"derivative":{"exercise_price":6.07,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":18351},"source":{"system":"sec-edgar","filing":"0001213900-21-046688","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390021046688/ownership.xml","form_type":"4"}},{"id":3057008,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10168,"kind":"person","name":"Chell Jeffrey W.","position":1,"cik":"0001738374","reported_name":"Chell Jeffrey W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-14T21:18:28.000Z","date":"2020-08-12","kind":"grant","acquired":true,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from August 12, 2020 until fully vested."}],"balance_after":8333,"derivative":{"exercise_price":9.55,"expiration_date":"2030-08-12","underlying":"Common Stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001213900-20-022339","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390020022339/ownership.xml","form_type":"4"}},{"id":3460576,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10168,"kind":"person","name":"Chell Jeffrey W.","position":1,"cik":"0001738374","reported_name":"Chell Jeffrey W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2019-07-16T21:16:25.000Z","date":"2019-07-12","kind":"grant","acquired":true,"shares":250000,"price":0.232,"value":58000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant."}],"balance_after":250000,"derivative":{"exercise_price":0.232,"expiration_date":"2029-07-12","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001213900-19-012888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390019012888/ownership.xml","form_type":"4"}},{"id":3865999,"issuer":{"id":7435,"kind":"organization","name":"Actinium Pharmaceuticals, Inc.","symbol":"ATNM"},"owners":[{"id":10168,"kind":"person","name":"Chell Jeffrey W.","position":1,"cik":"0001738374","reported_name":"Chell Jeffrey W.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2018-07-17T21:18:21.000Z","date":"2018-07-13","kind":"grant","acquired":true,"shares":75000,"price":0.7829,"value":58717.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant."}],"balance_after":75000,"derivative":{"exercise_price":0.7829,"expiration_date":"2028-07-13","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001213900-18-009325","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1388320/000121390018009325/ownership.xml","form_type":"4"}}]}